Vladmir Cláudio Cordeiro de Lima

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 580 citations

Medicine, Hematology, Oncology +12

HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer

Luciana de Moura Leite, Marcelle Goldner Cesca, Monique Celeste Tavares et al. · Breast Cancer Research and Treatment · 2021 · 184 citations

Medicine, Oncology, Breast Oncology +14

Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas

Gabriela Sarti Kinker, Glauco Akelinghton Freire Vitiello, Ariane Barros Diniz et al. · Gut · 2023 · 110 citations

Life Sciences, Immunology, Oncology +17

PD-L1 expression by Tumor Proportion Score (TPS) and Combined Positive Score (CPS) are similar in non-small cell lung cancer (NSCLC)

Pedro De Marchi, Letícia Ferro Leal, Vinícius Duval da Silva et al. · Journal of Clinical Pathology · 2021 · 100 citations

Medicine, Oncology, Pathology +17

Lung Cancer in Brazil

Clarissa Mathias, Gustavo Faibischew Prado, Eldsamira Mascarenhas et al. · Journal of Thoracic Oncology · 2020 · 78 citations · Full text

Medicine, Oncology, Cancer Epidemiology +6